Create Medic: Q3 sales grew 4.1%, but operating profit fell 44.2% amid cost pressure

What happened

Create Medic reported that third-quarter year-to-date revenue rose 4.1%, led by sales of its own brands, while operating profit fell 44.2% amid higher costs and selling, general and administrative expenses. Its FY2026 guidance targets 2.5% revenue growth and a 24.4% operating-profit decline as overseas expansion continues.

Confirmed

Global impact / market context

The figures point to a gap between sales growth and profit: higher costs and selling, general and administrative expenses, or SG&A, reduced operating profit despite stronger revenue. If that pattern continues, the company may have less cash available to fund overseas expansion or withstand further cost increases.

Analyst inference

The supplied summary describes growth led by own-brand sales alongside rising costs and continued overseas expansion, but gives no detail on which costs increased or how expansion is funded. Investors therefore have limited evidence to judge whether profit pressure is temporary or tied to expansion spending.

Analyst inference

What to watch

1. Compare later revenue and operating-profit results with FY2026 guidance to see whether sales growth continues while costs keep reducing profit. Analyst inference
2. Look for details on which costs and SG&A increased, since that would clarify whether the profit decline reflects ongoing pressure or a temporary rise. Analyst inference
3. Track updates on overseas expansion and own-brand sales; stronger sales could support revenue, while expansion costs may weigh on operating profit. Analyst inference

Evidence

• Original source link unavailable